KOL Perspectives: Adaptive Trial Designs in IBD
Summary
This KOL Insight briefing focuses on KOLs views of Adaptive trial designs in IBD.
Questions topics -
- Current challenges in IBD clinical trials
- Adaptive Phase II/III trial designs
- Guselkumab’s Phase II/III trial in Crohn’s disease
- Novel clinical trials in IBD
Key Highlights
- Most KOLs highlighted that recruitment is the greatest challenge in IBD clinical trials, both across Crohn’s disease & UC
- Most KOLs flagged Phase II/III
Read More
- Table of Contents
- Executive Summary
- Background
- Research Panel Composition
- Results & Implications
- Appendix
Read More